239 related articles for article (PubMed ID: 443293)
1. Effects of long-term estrogen replacement therapy. I. Metabolic effects.
Hammond CB; Jelovsek FR; Lee KL; Creasman WT; Parker RT
Am J Obstet Gynecol; 1979 Mar; 133(5):525-36. PubMed ID: 443293
[TBL] [Abstract][Full Text] [Related]
2. Effects of long-term estrogen replacement therapy. II. Neoplasia.
Hammond CB; Jelovsek FR; Lee KL; Creasman WT; Parker RT
Am J Obstet Gynecol; 1979 Mar; 133(5):537-47. PubMed ID: 220875
[TBL] [Abstract][Full Text] [Related]
3. Does estrogen cause adenocarcinoma of the endometrium?
Schwarz BE
Clin Obstet Gynecol; 1981 Mar; 24(1):243-51. PubMed ID: 7011637
[TBL] [Abstract][Full Text] [Related]
4. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
Gambrell RD
Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
[TBL] [Abstract][Full Text] [Related]
5. Risk of exogenous estrogen therapy and endometrial cancer.
Jelovsek FR; Hammond CB; Woodard BH; Draffin R; Lee KL; Creasman WT; Parker RT
Am J Obstet Gynecol; 1980 May; 137(1):85-91. PubMed ID: 7369293
[TBL] [Abstract][Full Text] [Related]
6. Estrogen replacement therapy: indications and complications.
Judd HL; Meldrum DR; Deftos LJ; Henderson BE
Ann Intern Med; 1983 Feb; 98(2):195-205. PubMed ID: 6824255
[TBL] [Abstract][Full Text] [Related]
7. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
8. Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.
Gambrell RD; Bagnell CA; Greenblatt RB
Am J Obstet Gynecol; 1983 Jul; 146(6):696-707. PubMed ID: 6307050
[TBL] [Abstract][Full Text] [Related]
9. Exogenous estrogen and endometrial carcinoma: case-control and incidence study.
McDonald TW; Annegers JF; O'Fallon WM; Dockerty MB; Malkasian GD; Kurland LT
Am J Obstet Gynecol; 1977 Mar; 127(6):572-80. PubMed ID: 190887
[TBL] [Abstract][Full Text] [Related]
10. Exogenous estrogens and endometrial cancer.
Gordan GS; Greenberg BG
Postgrad Med; 1976 Jun; 59(6):66-77. PubMed ID: 778818
[TBL] [Abstract][Full Text] [Related]
11. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
12. Endocrine factors in endometrial carcinoma. A preliminary report.
Dunn LJ; Bradbury JT
Am J Obstet Gynecol; 1967 Feb; 97(4):465-71. PubMed ID: 6016348
[TBL] [Abstract][Full Text] [Related]
13. Reduced incidence of endometrial cancer among postmenopausal women treated with progestogens.
Gambrell RD; Massey FM; Castaneda TA; Ugenas AJ; Ricci CA
J Am Geriatr Soc; 1979 Sep; 27(9):389-94. PubMed ID: 469150
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of cancer of the endometrium.
Mahboubi E; Eyler N; Wynder EL
Clin Obstet Gynecol; 1982 Mar; 25(1):5-17. PubMed ID: 7039906
[TBL] [Abstract][Full Text] [Related]
15. Turner's syndrome: results of estrogen therapy.
Gidwani GP; Seiler JC; Ballard LA
Cleve Clin Q; 1979; 46(1):19-22. PubMed ID: 436270
[TBL] [Abstract][Full Text] [Related]
16. The adverse effects of hormonal therapy.
Bush TL
Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
[TBL] [Abstract][Full Text] [Related]
17. Exogenous estrogens and endometrial carcinoma: review and comments for the clinician.
Berger GS; Fowler WC
J Reprod Med; 1977 Apr; 18(4):177-80. PubMed ID: 870690
[TBL] [Abstract][Full Text] [Related]
18. Pill-a-month as an oral contraceptive.
Hefnawi F; Hassanein M; Younis N
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
[TBL] [Abstract][Full Text] [Related]
19. Endometrial carcinoma after cyclical oestrogen-progestogen therapy for Turner's syndrome.
McCarroll AM; Montgomery DA; Harley JM; McKeown EF; MacHenry JC
Br J Obstet Gynaecol; 1975 May; 82(5):421-3. PubMed ID: 1137707
[TBL] [Abstract][Full Text] [Related]
20. Oestrogen replacement and endometrial cancer. A statement by the British Gynaecological Cancer Group.
Lancet; 1981 Jun; 1(8234):1359-60. PubMed ID: 6113323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
